Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study
Pei‐Yun Zhou(Fudan University), Shuang–Jian Qiu(Fudan University), Chao‐Ping Yang(Central South University), Guozhong Gong(Central South University), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Wei‐Ren Liu(Chung Yuan Christian University), Cheng Zhou(Fudan University), Yong Yi(Sun Yat-sen University), Bao‐Ye Sun(Fudan University), Zhi Dai(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Han Wang(Hebei Agricultural University), Jia Fan(Nanjing Tech University), Zheng Tang(Ministry of Education of the People's Republic of China), Yuan Fang(Guangzhou University of Chinese Medicine), Shushu Song(Fudan University), Wei Gan(Fudan University), Meng‐Xin Tian(Sun Yat-sen University), Jinlong Huang(Memorial Sloan Kettering Cancer Center), Ruo‐Yu Guan(Fudan University), Xi‐Fei Jiang(Sun Yat-sen University), Zhen‐Bin Ding(Fudan University), Yufu Zhou(Central South University), Yuan‐Fei Peng(Fudan University)
Cited by 8
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828